Cargando…

The effect of 5‐HT(1A) receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats

BACKGROUND AND PURPOSE: l‐DOPA prolonged treatment leads to disabling motor complications as dyskinesia that could be decreased by drugs acting on 5‐HT(1A) receptors. Since the internal segment of the globus pallidus, homologous to the entopeduncular nucleus in rodents, seems to be involved in the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Vegas‐Suárez, Sergio, Aristieta, Asier, Requejo, Catalina, Bengoetxea, Harkaitz, Lafuente, José Vicente, Miguelez, Cristina, Ugedo, Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252460/
https://www.ncbi.nlm.nih.gov/pubmed/33686657
http://dx.doi.org/10.1111/bph.15437
_version_ 1783717305577897984
author Vegas‐Suárez, Sergio
Aristieta, Asier
Requejo, Catalina
Bengoetxea, Harkaitz
Lafuente, José Vicente
Miguelez, Cristina
Ugedo, Luisa
author_facet Vegas‐Suárez, Sergio
Aristieta, Asier
Requejo, Catalina
Bengoetxea, Harkaitz
Lafuente, José Vicente
Miguelez, Cristina
Ugedo, Luisa
author_sort Vegas‐Suárez, Sergio
collection PubMed
description BACKGROUND AND PURPOSE: l‐DOPA prolonged treatment leads to disabling motor complications as dyskinesia that could be decreased by drugs acting on 5‐HT(1A) receptors. Since the internal segment of the globus pallidus, homologous to the entopeduncular nucleus in rodents, seems to be involved in the etiopathology of l‐DOPA‐induced dyskinesia, we investigated whether the entopeduncular nucleus is modulated by the 5‐HT(1A) receptor partial and full agonists, buspirone, and 8‐hydroxy‐2‐(di‐n‐propylamino)‐tetralin (8‐OH‐DPAT) in control and 6‐hydroxydopamine (6‐OHDA)‐lesioned rats with or without long‐term l‐DOPA treatment. EXPERIMENTAL APPROACH: Extracellular single‐unit electrocorticogram and local field potential recordings under anaesthesia, immunostaining assays and optogenetic manipulation coupled to electrophysiological recordings were performed. KEY RESULTS: Systemic buspirone reduced the entopeduncular nucleus firing rate in the sham animals and burst activity in the 6‐OHDA‐lesioned rats (with or without l‐DOPA treatment), while local administration reduced entopeduncular nucleus activity in all the groups, regardless of DA integrity. Systemic 8‐OH‐DPAT also induced inhibitory effects only in the sham animals. Effects triggered by buspirone and 8‐OH‐DPAT were reversed by the 5‐HT(1A) receptor antagonist, WAY‐100635. Neither buspirone nor 8‐OH‐DPAT modified the low‐frequency oscillatory activity in the entopeduncular nucleus or its synchronization with the motor cortex. Buspirone did not alter the response induced by subthalamic nucleus opto‐stimulation in the entopeduncular nucleus. CONCLUSION AND IMPLICATIONS: Systemic 5‐HT(1A) receptor activation elicits different effects on the electrophysiological properties of the entopeduncular nucleus depending on the integrity of the nigrostriatal pathway and it does not alter the relationship between subthalamic nucleus and entopeduncular nucleus neuron activity.
format Online
Article
Text
id pubmed-8252460
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82524602021-07-07 The effect of 5‐HT(1A) receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats Vegas‐Suárez, Sergio Aristieta, Asier Requejo, Catalina Bengoetxea, Harkaitz Lafuente, José Vicente Miguelez, Cristina Ugedo, Luisa Br J Pharmacol Research Papers BACKGROUND AND PURPOSE: l‐DOPA prolonged treatment leads to disabling motor complications as dyskinesia that could be decreased by drugs acting on 5‐HT(1A) receptors. Since the internal segment of the globus pallidus, homologous to the entopeduncular nucleus in rodents, seems to be involved in the etiopathology of l‐DOPA‐induced dyskinesia, we investigated whether the entopeduncular nucleus is modulated by the 5‐HT(1A) receptor partial and full agonists, buspirone, and 8‐hydroxy‐2‐(di‐n‐propylamino)‐tetralin (8‐OH‐DPAT) in control and 6‐hydroxydopamine (6‐OHDA)‐lesioned rats with or without long‐term l‐DOPA treatment. EXPERIMENTAL APPROACH: Extracellular single‐unit electrocorticogram and local field potential recordings under anaesthesia, immunostaining assays and optogenetic manipulation coupled to electrophysiological recordings were performed. KEY RESULTS: Systemic buspirone reduced the entopeduncular nucleus firing rate in the sham animals and burst activity in the 6‐OHDA‐lesioned rats (with or without l‐DOPA treatment), while local administration reduced entopeduncular nucleus activity in all the groups, regardless of DA integrity. Systemic 8‐OH‐DPAT also induced inhibitory effects only in the sham animals. Effects triggered by buspirone and 8‐OH‐DPAT were reversed by the 5‐HT(1A) receptor antagonist, WAY‐100635. Neither buspirone nor 8‐OH‐DPAT modified the low‐frequency oscillatory activity in the entopeduncular nucleus or its synchronization with the motor cortex. Buspirone did not alter the response induced by subthalamic nucleus opto‐stimulation in the entopeduncular nucleus. CONCLUSION AND IMPLICATIONS: Systemic 5‐HT(1A) receptor activation elicits different effects on the electrophysiological properties of the entopeduncular nucleus depending on the integrity of the nigrostriatal pathway and it does not alter the relationship between subthalamic nucleus and entopeduncular nucleus neuron activity. John Wiley and Sons Inc. 2021-05-06 2021-06 /pmc/articles/PMC8252460/ /pubmed/33686657 http://dx.doi.org/10.1111/bph.15437 Text en © 2021 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Papers
Vegas‐Suárez, Sergio
Aristieta, Asier
Requejo, Catalina
Bengoetxea, Harkaitz
Lafuente, José Vicente
Miguelez, Cristina
Ugedo, Luisa
The effect of 5‐HT(1A) receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats
title The effect of 5‐HT(1A) receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats
title_full The effect of 5‐HT(1A) receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats
title_fullStr The effect of 5‐HT(1A) receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats
title_full_unstemmed The effect of 5‐HT(1A) receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats
title_short The effect of 5‐HT(1A) receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats
title_sort effect of 5‐ht(1a) receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats
topic Research Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252460/
https://www.ncbi.nlm.nih.gov/pubmed/33686657
http://dx.doi.org/10.1111/bph.15437
work_keys_str_mv AT vegassuarezsergio theeffectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats
AT aristietaasier theeffectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats
AT requejocatalina theeffectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats
AT bengoetxeaharkaitz theeffectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats
AT lafuentejosevicente theeffectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats
AT miguelezcristina theeffectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats
AT ugedoluisa theeffectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats
AT vegassuarezsergio effectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats
AT aristietaasier effectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats
AT requejocatalina effectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats
AT bengoetxeaharkaitz effectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats
AT lafuentejosevicente effectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats
AT miguelezcristina effectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats
AT ugedoluisa effectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats